darolutamide,osimertinib,enzalutamide
astrazeneca
['enzalutamide', 'enzalu', 'darolutamide', 'osimertinib']
poster sessions well underway today #aacr2023. dr. john schmitz shares his study showing that darolutamide and enzalutamide overcome osimertinib resistance in #nscl. 
NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet